3-D Matrix Ltd (7777) - Product Pipeline Analysis, 2018 Update

3-D Matrix Ltd (7777) - Product Pipeline Analysis, 2018 Update

Nov 2018 GlobalData 3D32 Pages Price :
$ 750
Summary

3-D Matrix Ltd (3-D Matrix) is a regenerative medicine company that focuses at commercializing its self-assembling peptide technology. It develops medical products by applying this technology under a license granted by Massachusetts Institute of Technology (MIT). The technology finds applications in the field of surgical and medical regenerative medicine, cell therapy and drug discovery. 3-D Matrix's lead product, PuraMatrix caters to periodontal bone regeneration. The company has several collaborative agreements with academic research institutions, enterprises and medical institutions. The company operates across the US, France, the Netherlands, China and Singapore. 3-D Matrix is headquartered in Chiyoda-ku, Tokyo, Japan.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company 3-D Matrix Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
3-D Matrix Ltd Company Overview 5
3-D Matrix Ltd Company Snapshot 5
3-D Matrix Ltd Pipeline Products and Ongoing Clinical Trials Overview 5
3-D Matrix Ltd Pipeline Analysis Overview 8
Business Description 8
3-D Matrix Ltd - Key Facts 8
3-D Matrix Ltd - Major Products and Services 9
3-D Matrix Ltd Pipeline Products by Development Stage 10
3-D Matrix Ltd Ongoing Clinical Trials by Trial Status 12
3-D Matrix Ltd Pipeline Products Overview 13
PuraMatrix Bone Void Filler 13
PuraMatrix Bone Void Filler Product Overview 13
PuraSINUS Gel 14
PuraSINUS Gel Product Overview 14
PuraStat Hemostat 15
PuraStat Hemostat Product Overview 15
PuraStat Hemostat Clinical Trial 16
TDM-511 17
TDM-511 Product Overview 17
TDM-623 18
TDM-623 Product Overview 18
TDM-641 19
TDM-641 Product Overview 19
TDM-651 20
TDM-651 Product Overview 20
3-D Matrix Ltd - Key Competitors 21
3-D Matrix Ltd - Key Employees 22
3-D Matrix Ltd - Key Employee Biographies 23
3-D Matrix Ltd - Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
3-D Matrix Ltd, Recent Developments 25
May 10, 2018: Partnership Agreement concluded with DEMEDIC regarding sales and marketing of absorbable local hemostat PuraStat in Argentina 25
Apr 28, 2016: Partnership Agreement concluded with Kaplan regarding sales and marketing of absorbable local hemostat PuraStat in Chile 25
Apr 05, 2016: Patent Granted for Cardiac Tissue Regeneration with Self-Assembling Peptide Technology in Japan 25
Feb 22, 2016: Absorbable Hemostat PuraStat Product Registration Obtained in Mexico 26
Feb 15, 2016: 3-D Matrix: Announcement of Change of Representative Directors 26
Jan 25, 2016: Absorbable Hemostat PuraStat Product Registration Obtained in Thailand 27
Jan 22, 2016: Absorbable Hemostat PuraStat Product Registration Obtained in Australia 27
Dec 28, 2015: Partnership Agreement concluded with Transmedic regarding sales and marketing of PuraStat in Singapore, Malaysia and Brunei 27
Nov 04, 2015: Absorbable Hemostat TDM-621 Product Registration Obtained in Brazil 28
Oct 05, 2015: Partnership Agreement concluded with Maquet Australia regarding sales and marketing of absorbable local hemostat PuraStatin Australia 28
Appendix 29
Methodology 29
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
3-D Matrix Ltd Pipeline Products and Ongoing Clinical Trials Overview 5
3-D Matrix Ltd Pipeline Products by Equipment Type 6
3-D Matrix Ltd Pipeline Products by Indication 7
3-D Matrix Ltd Ongoing Clinical Trials by Trial Status 7
3-D Matrix Ltd, Key Facts 8
3-D Matrix Ltd, Major Products and Services 9
3-D Matrix Ltd Number of Pipeline Products by Development Stage 10
3-D Matrix Ltd Pipeline Products Summary by Development Stage 11
3-D Matrix Ltd Ongoing Clinical Trials by Trial Status 12
3-D Matrix Ltd Ongoing Clinical Trials Summary 12
PuraMatrix Bone Void Filler - Product Status 13
PuraMatrix Bone Void Filler - Product Description 13
PuraSINUS Gel - Product Status 14
PuraSINUS Gel - Product Description 14
PuraStat Hemostat - Product Status 15
PuraStat Hemostat - Product Description 15
PuraStat Hemostat - A Multi-center, Single Arm Post-market Clinical Study to Confirm Safety and Performance of PuraStat Absorbable Haemostatic Material for the Management of Bleeding in Vascular Surgery 16
TDM-511 - Product Status 17
TDM-511 - Product Description 17
TDM-623 - Product Status 18
TDM-623 - Product Description 18
TDM-641 - Product Status 19
TDM-641 - Product Description 19
TDM-651 - Product Status 20
TDM-651 - Product Description 20
3-D Matrix Ltd, Key Employees 22
3-D Matrix Ltd, Key Employee Biographies 23
3-D Matrix Ltd, Subsidiaries 24
Glossary 31

List of Figures
3-D Matrix Ltd Pipeline Products by Equipment Type 6
3-D Matrix Ltd Pipeline Products by Development Stage 10
3-D Matrix Ltd Ongoing Clinical Trials by Trial Status 12

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Country :
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 750
$ 1500

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top